| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC1966 |
| Trial ID | NCT03661554 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma |
| Year | 2018 |
| Country | China |
| Company sponsor | The Pregene (ShenZhen) Biotechnology Company, Ltd. |
| Other ID(s) | PRG 1801 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||